1
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017.PubMed/NCBI View Article : Google Scholar
|
2
|
Rahib L, Smith BD, Aizenberg R, Rosenzweig
AB, Fleshman JM and Matrisian LM: Projecting cancer incidence and
deaths to 2030: The unexpected burden of thyroid, liver, and
pancreas cancers in the United States. Cancer Res. 74:2913–2921.
2014.PubMed/NCBI View Article : Google Scholar
|
3
|
Ryan DP, Hong TS and Bardeesy N:
Pancreatic adenocarcinoma. N Engl J Med. 371:1039–1049.
2014.PubMed/NCBI View Article : Google Scholar
|
4
|
Feng L, Gu S, Wang P, Chen H, Chen Z, Meng
Z and Liu L: Pretreatment values of bilirubin and albumin are not
prognostic predictors in patients with advanced pancreatic cancer.
Cancer Med. 7:5943–5951. 2018.PubMed/NCBI View Article : Google Scholar
|
5
|
Johnson CD, Schwall G, Flechtenmacher J
and Trede M: Resection for adenocarcinoma of the body and tail of
the pancreas. Br J Surg. 80:1177–1179. 1993.PubMed/NCBI View Article : Google Scholar
|
6
|
Shoup M, Conlon KC, Klimstra D and Brennan
MF: Is extended resection for adenocarcinoma of the body or tail of
the pancreas justified? J Gastrointest Surg. 7:946–952; discussion
952. 2003.PubMed/NCBI View Article : Google Scholar
|
7
|
Artinyan A, Soriano PA, Prendergast C, Low
T, Ellenhorn JD and Kim J: The anatomic location of pancreatic
cancer is a prognostic factor for survival. HPB (Oxford).
10:371–376. 2008.PubMed/NCBI View Article : Google Scholar
|
8
|
Lau MK, Davila JA and Shaib YH: Incidence
and survival of pancreatic head and body and tail cancers: A
population-based study in the United States. Pancreas. 39:458–462.
2010.PubMed/NCBI View Article : Google Scholar
|
9
|
Lee GH, Malietzis G, Askari A, Bernardo D,
Al-Hassi HO and Clark SK: Is right-sided colon cancer different to
left-sided colorectal cancer? - a systematic review. Eur J Surg
Oncol. 41:300–308. 2015.PubMed/NCBI View Article : Google Scholar
|
10
|
Loupakis F, Yang D, Yau L, Feng S,
Cremolini C, Zhang W, Maus MK, Antoniotti C, Langer C, Scherer SJ,
et al: Primary tumor location as a prognostic factor in metastatic
colorectal cancer. J Natl Cancer Inst. 107(107)2015.PubMed/NCBI View Article : Google Scholar
|
11
|
Missiaglia E, Jacobs B, D'Ario G, Di Narzo
AF, Soneson C, Budinska E, Popovici V, Vecchione L, Gerster S, Yan
P, et al: Distal and proximal colon cancers differ in terms of
molecular, pathological, and clinical features. Ann Oncol.
25:1995–2001. 2014.PubMed/NCBI View Article : Google Scholar
|
12
|
Weiss JM, Pfau PR, O'Connor ES, King J,
LoConte N, Kennedy G and Smith MA: Mortality by stage for right-
versus left-sided colon cancer: Analysis of surveillance,
epidemiology, and end results - Medicare data. J Clin Oncol.
29:4401–4409. 2011.PubMed/NCBI View Article : Google Scholar
|
13
|
Weiss JM, Schumacher J, Allen GO, Neuman
H, Lange EO, Loconte NK, Greenberg CC and Smith MA: Adjuvant
chemotherapy for stage II right-sided and left-sided colon cancer:
Analysis of SEER-medicare data. Ann Surg Oncol. 21:1781–1791.
2014.PubMed/NCBI View Article : Google Scholar
|
14
|
Meguid RA, Slidell MB, Wolfgang CL, Chang
DC and Ahuja N: Is there a difference in survival between right-
versus left-sided colon cancers? Ann Surg Oncol. 15:2388–2394.
2008.PubMed/NCBI View Article : Google Scholar
|
15
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: the 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474.
2010.PubMed/NCBI View Article : Google Scholar
|
16
|
Uchida T, Takada T, Ammori BJ, Suda K and
Takahashi T: Three-dimensional reconstruction of the ventral and
dorsal pancreas: A new insight into anatomy and embryonic
development. J Hepatobiliary Pancreat Surg. 6:176–180.
1999.PubMed/NCBI View Article : Google Scholar
|
17
|
Malaisse-Lagae F, Orci L and Perrelet A:
Anatomic and hormonal markers for the ventral primordium in the
human pancreas? N Engl J Med. 300(436)1979.PubMed/NCBI View Article : Google Scholar
|
18
|
Baetens D, Malaisse-Lagae F, Perrelet A
and Orci L: Endocrine pancreas: Three-dimensional reconstruction
shows two types of islets of langerhans. Science. 206:1323–1325.
1979.PubMed/NCBI View Article : Google Scholar
|
19
|
Kamisawa T, Wood LD, Itoi T and Takaori K:
Pancreatic cancer. Lancet. 388:73–85. 2016.PubMed/NCBI View Article : Google Scholar
|
20
|
Conroy T, Desseigne F, Ychou M, Bouché O,
Guimbaud R, Bécouarn Y, Adenis A, Raoul JL, Gourgou-Bourgade S, de
la Fouchardière C, et al: Groupe Tumeurs Digestives of Unicancer;
PRODIGE Intergroup: FOLFIRINOX versus gemcitabine for metastatic
pancreatic cancer. N Engl J Med. 364:1817–1825. 2011.PubMed/NCBI View Article : Google Scholar
|
21
|
Uesaka K, Boku N, Fukutomi A, Okamura Y,
Konishi M, Matsumoto I, Kaneoka Y, Shimizu Y, Nakamori S, Sakamoto
H, et al: JASPAC 01 Study Group: Adjuvant chemotherapy of S-1
versus gemcitabine for resected pancreatic cancer: A phase 3,
open-label, randomised, non-inferiority trial (JASPAC 01). Lancet.
388:248–257. 2016.PubMed/NCBI View Article : Google Scholar
|
22
|
Von Hoff DD, Ervin T, Arena FP, Chiorean
EG, Infante J, Moore M, Seay T, Tjulandin SA, Ma WW, Saleh MN, et
al: Increased survival in pancreatic cancer with nab-paclitaxel
plus gemcitabine. N Engl J Med. 369:1691–1703. 2013.PubMed/NCBI View Article : Google Scholar
|
23
|
Wang-Gillam A, Li CP, Bodoky G, Dean A,
Shan YS, Jameson G, Macarulla T, Lee KH, Cunningham D, Blanc JF, et
al: NAPOLI-1 Study Group: Nanoliposomal irinotecan with
fluorouracil and folinic acid in metastatic pancreatic cancer after
previous gemcitabine-based therapy (NAPOLI-1): A global,
randomised, open-label, phase 3 trial. Lancet. 387:545–557.
2016.PubMed/NCBI View Article : Google Scholar
|
24
|
Regine WF, Winter KA, Abrams RA, Safran H,
Hoffman JP, Konski A, Benson AB, Macdonald JS, Kudrimoti MR, Fromm
ML, et al: Fluorouracil vs gemcitabine chemotherapy before and
after fluorouracil-based chemoradiation following resection of
pancreatic adenocarcinoma: A randomized controlled trial. JAMA.
299:1019–1026. 2008.PubMed/NCBI View Article : Google Scholar
|
25
|
Cheng L, Eng C, Nieman LZ, Kapadia AS and
Du XL: Trends in colorectal cancer incidence by anatomic site and
disease stage in the United States from 1976 to 2005. Am J Clin
Oncol. 34:573–580. 2011.PubMed/NCBI View Article : Google Scholar
|
26
|
Christein JD, Kendrick ML, Iqbal CW,
Nagorney DM and Farnell MB: Distal pancreatectomy for resectable
adenocarcinoma of the body and tail of the pancreas. J Gastrointest
Surg. 9:922–927. 2005.PubMed/NCBI View Article : Google Scholar
|